GLIOBLASTOMA BN007

Study #BN007

A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients with Newly Diagnosed MGMT (Tumor 0-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma

Back To Clinical Trials